Chiron receives Fluvirin subpoena

In an 8-K filing, CHIR said it received a grand jury subpoena from the U.S. Attorney's Office for the Southern District of New York on Oct. 11, requesting materials related to the suspension of its license to manufacture Fluvirin influenza vaccine (see BioCentury Extra, Tuesday Oct. 5, 2004). The company said it will cooperate with the investigation. ...